contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


mod-ledelsen-i-danske-bank-ascelia-pharma-gronlandsbanken-og-gomspace-og-stil-sporgsmal-til-dagens-investorpraesentationer

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Equity Research Analyst

Philip Coombes

Danske Bank was founded in 1871 and is Denmark’s largest bank, with headquarters in Copenhagen and activities in Denmark, Sweden, Norway, Finland, Northern Ireland, and the United Kingdom. Danske Bank is engaged in providing payment services, trading in securities and other instruments, depositing of surplus liquidity and the provision of short- and long-term financing. It operates four commercial business units Personal & Business Customers, Large Corporates & Institutions, Danica Pension, and Northern Ireland.

The Personal & Business Customers segment provides advisory services to personal customers, Private Banking customers and small and medium-sized businesses in Denmark, Sweden, Norway and Finland. Its Large Corporates & Institutions segment is engaged with providing strategic advice, financial solutions and products to large Nordic and institutional customers. Danica Pension provides pension services within Denmark, and in its Northern Ireland segment, Danske Bank serves personal business and corporate customers in Northern Ireland with some activities in targeted sectors across the rest of the United Kingdom.

In 2021 Danske Bank’s market share in Denmark was 25% in lending and 29% in deposits.

Danske Bank

Ascelia Pharma is a Swedish biotech company with a focus on orphan oncology treatments. They develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Currently, Ascelia pharma has two pipeline products, namely Orviglance and Oncoral. Orviglance is a novel contrast agent for MR-Imaging developed to improve the detecting and visualization of focal liver lesions (Including liver metastases – and primary tumors) in patients with reduced kidney function. Oncoral is a daily tablet with an established potent anti-tumor effect – even in difficult to treat cancers with the potential to offer better patient outcomes with improved safety following a daily tablet treatment compared to intravenous high-dose infusions at the hospital.

Ascelia Pharma is listed on Nasdaq Small Cap Stockholm with ticker ACE.

Ascelia Pharma

Grønlandsbanken is a bank that offers financial services in Greenland. The bank mainly provides traditional services for loan financing, asset management and insurance issues, both aimed at private and corporate customers. A large part of the services are offered digitally. The company was founded in 1967 and is headquartered in Nuuk, Greenland.

Grønlandsbanken

Gomspace Group is an IT company. The company develops, designs, and sells nanosatellites. The products are developed to deliver tracking, communication, and cyber security. They are used in several industries, including defense and security, aviation, and telecommunications. Gomspace Group operates worldwide and has its located in headquarters in Aalborg.

GomSpace Group

Mød ledelsen i Danske Bank, Ascelia Pharma, GrønlandsBANKEN og GomSpace og stil spørgsmål til dagens investorpræsentationer

Her til formiddag kl. 11:00 vil Danske Bank Head of Investor Relations, Claus I. Jensen, pr&#xe6;sentere resultaterne for Q3 2025 og svare p&#xe5; sp&#xf8;rgsm&#xe5;l fra tilh&#xf8;rerne. Tilmeld dig og stil dine sp&#xf8;rgsm&#xe5;l allerede&#xa0;nu: <a href="https://www.inderes.dk/videos/danske-bank-praesentation-af-regnskabet-for-3-kvartal-2025">https://www.inderes.dk/videos/danske-bank-praesentation-af-regnskabet-for-3-kvartal-2025</a>
Kl. 12:00 vil Ascelia Pharma Deputy CEO og CCO, Julie Waras Brogren, pr&#xe6;sentere resultaterne for Q3 2025 og svare p&#xe5; sp&#xf8;rgsm&#xe5;l fra tilh&#xf8;rerne. Tilmeld dig og stil dine sp&#xf8;rgsm&#xe5;l allerede&#xa0;nu: <a href="https://www.inderes.dk/videos/ascelia-pharma-presentation-of-interim-q3-2025-report">https://www.inderes.dk/videos/ascelia-pharma-presentation-of-interim-q3-2025-report</a>
Her til eftermiddag kl. 14:00 vil Gr&#xf8;nlandsBANKENs bankdirekt&#xf8;r, Martin Kviesgaard, pr&#xe6;sentere resultaterne for Q3 2025 og svare p&#xe5; sp&#xf8;rgsm&#xe5;l fra tilh&#xf8;rerne. Tilmeld dig og stil dine sp&#xf8;rgsm&#xe5;l allerede&#xa0;nu: <a href="https://www.inderes.dk/videos/gronlandsbanken-praesentation-af-regnskabet-for-3-kvartal-2025">https://www.inderes.dk/videos/gronlandsbanken-praesentation-af-regnskabet-for-3-kvartal-2025</a>
Kl. 15:00 vil GomSpace CEO, Carsten Drachmann, pr&#xe6;sentere resultaterne for Q3 2025 og svare p&#xe5; sp&#xf8;rgsm&#xe5;l fra tilh&#xf8;rerne. Tilmeld dig og stil dine sp&#xf8;rgsm&#xe5;l allerede&#xa0;nu: <a href="https://www.inderes.dk/videos/gomspace-presentation-of-q3-2025-trading-statement">https://www.inderes.dk/videos/gomspace-presentation-of-q3-2025-trading-statement</a>
Disclaimer: HC Andersen Capital modtager betaling fra de n&#xe6;vnte selskaber for en digital IR abonnementsaftale. /Philip Coombes d. 06/11-2025 kl. 08:45

Stay up to date